637 related articles for article (PubMed ID: 19419332)
1. Reclassification of Staphylococcus aureus nasal carriage types.
van Belkum A; Verkaik NJ; de Vogel CP; Boelens HA; Verveer J; Nouwen JL; Verbrugh HA; Wertheim HF
J Infect Dis; 2009 Jun; 199(12):1820-6. PubMed ID: 19419332
[TBL] [Abstract][Full Text] [Related]
2. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
4. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
5. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
[TBL] [Abstract][Full Text] [Related]
6. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule".
Nouwen JL; Ott A; Kluytmans-Vandenbergh MF; Boelens HA; Hofman A; van Belkum A; Verbrugh HA
Clin Infect Dis; 2004 Sep; 39(6):806-11. PubMed ID: 15472812
[TBL] [Abstract][Full Text] [Related]
7. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
Creech CB; Johnson BG; Alsentzer AR; Hohenboken M; Edwards KM; Talbot TR
Vaccine; 2009 Dec; 28(1):256-60. PubMed ID: 19799842
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
9. Human factor in Staphylococcus aureus nasal carriage.
Nouwen J; Boelens H; van Belkum A; Verbrugh H
Infect Immun; 2004 Nov; 72(11):6685-8. PubMed ID: 15501803
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cutaneous bacterial infections and nasal carriage of Staphylococcus aureus in recipients of renal transplants.
Ada S; Seçkin D; Azap O; Budakoğlu I; Haberal M
Clin Exp Dermatol; 2009 Mar; 34(2):156-60. PubMed ID: 19187296
[TBL] [Abstract][Full Text] [Related]
11. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
12. Nasal and hand carriage of Staphylococcus aureus in healthcare workers.
Doebbeling BN
J Chemother; 1994 Apr; 6 Suppl 2():11-7. PubMed ID: 7799050
[TBL] [Abstract][Full Text] [Related]
13. Nasal carriage of Staphylococcus aureus among healthy adults.
Choi CS; Yin CS; Bakar AA; Sakewi Z; Naing NN; Jamal F; Othman N
J Microbiol Immunol Infect; 2006 Dec; 39(6):458-64. PubMed ID: 17164947
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
Boelaert JR
J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
[TBL] [Abstract][Full Text] [Related]
15. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
[TBL] [Abstract][Full Text] [Related]
16. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.
Kluytmans JA; Wertheim HF
Infection; 2005 Feb; 33(1):3-8. PubMed ID: 15750752
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis.
Holtfreter S; Roschack K; Eichler P; Eske K; Holtfreter B; Kohler C; Engelmann S; Hecker M; Greinacher A; Broker BM
J Infect Dis; 2006 May; 193(9):1275-8. PubMed ID: 16586365
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes.
Panierakis C; Goulielmos G; Mamoulakis D; Maraki S; Papavasiliou E; Galanakis E
Int J Infect Dis; 2009 Nov; 13(6):e437-43. PubMed ID: 19411183
[TBL] [Abstract][Full Text] [Related]
19. Induction of antibodies by Staphylococcus aureus nasal colonization in young children.
Verkaik NJ; Lebon A; de Vogel CP; Hooijkaas H; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; van Wamel WJ
Clin Microbiol Infect; 2010 Aug; 16(8):1312-7. PubMed ID: 19832714
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
